Authors recorded significantly higher levels of serum GIP-10 in COVID-19 patients, where they also observed a significantly higher level of GIP-10 in critical and severe conditions compared to mild and moderate conditions of COVID-19. The gene discussed is CXCL10; the disease is COVID-19.